107 related articles for article (PubMed ID: 26472564)
21. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.
Ghi MG; Paccagnella A; D'Amanzo P; Mione CA; Fasan S; Paro S; Mastromauro C; Carnuccio R; Turcato G; Gatti C; Pallini A; Nascimben O; Biason R; Oniga F; Medici M; Rossi F; Fila G
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):481-7. PubMed ID: 15145166
[TBL] [Abstract][Full Text] [Related]
22. Dexamethasone does not significantly contribute to the response rate of docetaxel and estramustine in androgen independent prostate cancer.
Weitzman AL; Shelton G; Zuech N; Owen CE; Judge T; Benson M; Sawczuk I; Katz A; Olsson CA; Bagiella E; Pfaff C; Newhouse JH; Petrylak DP
J Urol; 2000 Mar; 163(3):834-7. PubMed ID: 10687988
[TBL] [Abstract][Full Text] [Related]
23. Retrospective analysis of premedication, glucocorticosteroids, and H
Ikegawa K; Suzuki S; Nomura H; Enokida T; Yamazaki T; Okano S; Endo K; Saito S; Yamaguchi M; Tahara M
J Int Med Res; 2017 Aug; 45(4):1378-1385. PubMed ID: 28606015
[TBL] [Abstract][Full Text] [Related]
24. Phase I/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck.
Fujii M; Tsukuda M; Satake B; Kubota A; Kida A; Kohno N; Okami K; Inuyama Y;
Int J Clin Oncol; 2004 Apr; 9(2):107-12. PubMed ID: 15108042
[TBL] [Abstract][Full Text] [Related]
25. Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck.
Schwartz DL; Montgomery RB; Yueh B; Donahue M; Anzai Y; Canby R; Buelna R; Anderson L; Boyd C; Hutson J; Keegan K
Cancer; 2005 Jun; 103(12):2534-43. PubMed ID: 15856475
[TBL] [Abstract][Full Text] [Related]
26. Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Specenier P; Rasschaert M; Vroman P; Van den Brande J; Dyck J; Schrijvers D; Huizing MT; Vermorken JB
Am J Clin Oncol; 2011 Oct; 34(5):472-7. PubMed ID: 20938321
[TBL] [Abstract][Full Text] [Related]
27. Phase I study of weekly docetaxel and cisplatin arterial infusion for recurrent head and neck cancer.
Nakamura T; Fuwa N; Takayama K; Inokuchi H; Tomoda T; Takada A; Makita C; Shiomi M; Yokouchi J; Watanabe K
Head Neck; 2012 Nov; 34(11):1634-9. PubMed ID: 22179897
[TBL] [Abstract][Full Text] [Related]
28. [Clinical analysis of premedication regimen with dexamethasone at different doses for docetaxel-induced hypersensitivity reaction].
Zhang MJ; Chen ZD; Pan YY
Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):795. PubMed ID: 20021838
[No Abstract] [Full Text] [Related]
29. A phase I study of bi-weekly combination therapy with S-1 and docetaxel for advanced or recurrent gastric cancer.
Rino Y; Takanashi Y; Yukawa N; Saeki H; Wada H; Kanari M; Yamada R; Satoh T; Yamamoto N; Imada T
Anticancer Res; 2006; 26(2B):1455-62. PubMed ID: 16619558
[TBL] [Abstract][Full Text] [Related]
30. Does dexamethasone inhibit the antineoplastic effect of cisplatin and docetaxel in head and neck cancer cells?
Wagenblast J; Arnoldner C; Gstöttner W; Bisdas S; Mörtel S; May A; Hambek M
Anticancer Res; 2010 Jan; 30(1):123-7. PubMed ID: 20150626
[TBL] [Abstract][Full Text] [Related]
31. Docetaxel, ifosfamide and cisplatin (DIP) in squamous cell carcinoma of the head and neck.
Specenier PM; Van Den Brande J; Schrijvers D; Huizing MT; Altintas S; Dyck J; Van Den Weyngaert D; Van Laer C; Vermorken JB
Anticancer Res; 2009 Dec; 29(12):5137-42. PubMed ID: 20044628
[TBL] [Abstract][Full Text] [Related]
32. Phase II study of weekly docetaxel and cisplatin in patients with advanced recurrent and metastatic head and neck cancer.
Guntinas-Lichius O; Appenrodt S; Veelken F; Krug B
Laryngoscope; 2006 Apr; 116(4):613-8. PubMed ID: 16585868
[TBL] [Abstract][Full Text] [Related]
33. Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
Recchia F; Saggio G; Cesta A; Amiconi G; di Blasio A; Candeloro G; Valeriani M; Tombolini V; Rea S
Anticancer Res; 2006; 26(3B):2317-24. PubMed ID: 16821609
[TBL] [Abstract][Full Text] [Related]
34. Low-Dose Docetaxel Combined with Dexamethasone Is Feasible for Patients with Castration-Resistant Prostate Cancer.
Miura N; Tanji N; Yanagihara Y; Noda T; Asai S; Nishimura K; Shirato A; Miyauchi Y; Kikugawa T; Yokoyama M
Chemotherapy; 2016; 61(1):23-31. PubMed ID: 26528957
[TBL] [Abstract][Full Text] [Related]
35. Prospective pilot study of consolidation chemotherapy with docetaxel and cisplatin after concurrent chemoradiotherapy for advanced head and neck cancer.
Lee KC; Lee SH; Lee Y; Park SH; Park J; Cho EK; Shin DB; Lee JH; Kim DY; Kim ST
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):187-91. PubMed ID: 17996392
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck.
Baghi M; Hambek M; May A; Radeloff A; Gstoettner W; Knecht R
Anticancer Res; 2006; 26(1B):559-63. PubMed ID: 16739320
[TBL] [Abstract][Full Text] [Related]
37. Carboplatin with weekly docetaxel and ifosfamide in advanced head and neck cancers: a phase I Brown University Oncology Group dose escalation study (HN-93).
Rathore R; Birnbaum A; Rathore B; DiPetrillo T; Kennedy T; Ready N
Cancer Chemother Pharmacol; 2010 Nov; 66(6):1013-7. PubMed ID: 20130878
[TBL] [Abstract][Full Text] [Related]
38. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Katori H; Tsukuda M; Watai K
Cancer Chemother Pharmacol; 2007 Aug; 60(3):399-406. PubMed ID: 17096160
[TBL] [Abstract][Full Text] [Related]
39. Phase I study of docetaxel and topotecan in patients with solid tumors.
Tkaczuk KH; Zamboni WC; Tait NS; Meisenberg BR; Doyle LA; Edelman MJ; Hausner PF; Egorin MJ; Van Echo DA
Cancer Chemother Pharmacol; 2000; 46(6):442-8. PubMed ID: 11138457
[TBL] [Abstract][Full Text] [Related]
40. Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer.
Gennari A; Guarneri V; Landucci E; Orlandini C; Rondini M; Salvadori B; Ricci S; Conte PF
Clin Breast Cancer; 2002 Dec; 3(5):346-52. PubMed ID: 12533265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
